HomeVRDN • NASDAQ
add
Viridian Therapeutics Inc
Previous close
$12.62
Day range
$12.48 - $13.09
Year range
$9.90 - $27.20
Market cap
1.07B USD
Avg Volume
975.38K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 72.00K | 0.00% |
Operating expense | 88.19M | 78.92% |
Net income | -86.91M | -79.04% |
Net profit margin | -120.71K | -79.04% |
Earnings per share | -0.87 | -10.13% |
EBITDA | -93.75M | -68.15% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 636.63M | 3.82% |
Total assets | 660.98M | 4.85% |
Total liabilities | 56.51M | 18.09% |
Total equity | 604.47M | — |
Shares outstanding | 81.59M | — |
Price to book | 2.48 | — |
Return on assets | -33.44% | — |
Return on capital | -35.49% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -86.91M | -79.04% |
Cash from operations | -92.65M | -104.88% |
Cash from investing | 100.06M | 169.95% |
Cash from financing | 9.21M | -94.80% |
Net change in cash | 16.62M | 248.59% |
Free cash flow | -62.68M | -128.84% |
About
Founded
2010
Headquarters
Website
Employees
143
